Silobreaker.com
360° SearchNetworkHot SpotsTrends
 
Advanced Search Options >>
Saturday, November 21, 2009 11:17 AM

Mentor Corporation

Type: Company
Name: Mentor Corporation
First Reported 11/17/2009 - Updated 11/17/2009 - 2 Documents (in Health)
The obsession of Americans to look young drives demand for cosmetic surgery products and procedures. Recent years have been glorious in the history of cosmetic surgery products and procedures, as new product approvals and technology improvements have ... [Yahoo! Canada - 11/17/2009]
First Reported 10/22/2009 - Updated 10/23/2009 - 4 Documents (in Internet & IT)
Research and Markets (http://www.researchandmarkets.com/research/7f4ac7/botulinum_toxin) has announced the addition of the "Botulinum Toxin - Global Strategic Business Report" report to their offering.This report analyzes the worldwide markets for Botulinum ... [News-Medical.Net - 10/23/2009]
First Reported 11/03/2009 - Updated 11/03/2009 - 1 Documents
Johnson & Johnson - Click to view image in its original context
Johnson & Johnson
BOSTON (MarketWatch) - Johnson & Johnson said early Tuesday that it plans to cut up to 7% of its roughly 117,000-person workforce, or about 8,200 jobs, in an effort to save between $1.4 billion and $1.7 billion a year in costs.J&J /quotes/comstock/13*!jnj/quotes/nls/jnj ... [MarketWatch - 11/03/2009]
First Reported 11/03/2009 - Updated 11/03/2009 - 1 Documents
Two weeks after (NYSE:JNJ) , which tugged stocks downward, the world's biggest healthcare company is . Those cuts include 7,000 to 8,000 layoffs, mostly overseas.J&J chief executive (pictured) said in a statement, 'These types of changes are difficult ... [TheDeal.com - 11/03/2009]
First Reported 10/13/2009 - Updated 10/13/2009 - 2 Documents (in Market News)
BOSTON (MarketWatch) -- Johnson & Johnson early Tuesday reported a 1% rise in third-quarter earnings, but its sales performance was tempered by declining sales of three of its top-selling prescription drugs, Topamax, Razadyne and Risperdal, due to increased ... [MarketWatch - 10/13/2009]
First Reported 10/13/2009 - Updated 10/13/2009 - 1 Documents (in Health)
Johnson & Johnson on Tuesday reported a meager 1 per cent increase in third-quarter profit, as intensifying generic competition slashed sales of blockbuster prescription drugs.In addition, the global recession hurt consumer product sales and slowed growth ... [Sydney Morning Herald - 10/13/2009]
First Reported 10/13/2009 - Updated 10/13/2009 - 1 Documents (in Market News)
Story Quotes Comments Screener (332)AlertEmail PrintBOSTON (MarketWatch) -- Johnson & Johnson early Tuesday reported moderately higher third-quarter earnings, but its sales performance was tempered by declining sales of two of its top-selling prescription ... [MarketWatch - 10/13/2009]

Quotes

...4 billion and 1.7 billion a year starting in 2011, which "will provide additional resources to invest in new growth platforms." It also confirmed its earnings guidance for 2009 of $4.54 to $4...

More Content

All (16) | News (14) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (2)
sort by: Date | Relevance
Research and Markets: Cosmetic Surgery Procedur... [Yahoo! Canada - 11/17/2009]
Research and Markets: Cosmetic Surgery Procedur... [RBC Dain Rauscher - 11/17/2009]
J&J chief calls job cuts 'difficult' [TheDeal.com - 11/03/2009]
J&J slashes    ... [MarketWatch - 11/03/2009]
Johnson & Johnson to cut up to 8,200 jobs [MarketWatch - 11/03/2009]
Research and Markets: Allergan Inc.: PharmaVita... [Zibb - 10/30/2009]
Report on worldwide markets for Botulinum Toxin [News-Medical.Net - 10/23/2009]
Research and Markets: This Essential and Compre... [Forbes.com - 10/22/2009]
Research and Markets: This Essential and Compre... [Business Wire - 10/22/2009]
Research and Markets: This Essential and Compre... [Individual.com - 10/22/2009]
Johnson & Johnson posts 1% profit rise desp... [Sydney Morning Herald - 10/13/2009]
J&J reports 1% profit rise despite lower sales [MarketWatch - 10/13/2009]
J&J reports higher earnings, despite lower ... [MarketWatch - 10/13/2009]
J&J reports moderately higher earnings [MarketWatch - 10/13/2009]
1

  •  
  •  
  •